Optimism correlated with lower incidence of type 2 in postmenopausal women.
Read More »Reducing End-Stage Kidney Disease Risk More Efficiently
Use of albuminuria level changes as the endpoint to determine need to reduce albumin-to-creatinine ratio.
Read More »Albuminuria Change and Risk of End-Stage Kidney Disease
Change in albuminuria as surrogate endpoint for progression of chronic kidney disease strongly supported by biological plausibility, but empirical evidence to support its validity in epidemiological studies lacking.
Read More »Elevated A1C Linked to Fractures in Diabetes
Researchers find increased risk in people with type 1 who have glucose levels greater than 8.0%.
Read More »Prolonged Sitting Can Increase Risk of Cardiovascular Disease?
Can sitting for just 3 hours non-stop at one time hurt the heart?
Read More »Albuminuria Change and Risk of End-Stage Kidney Disease
Change in albuminuria as a surrogate endpoint for progression of chronic kidney disease strongly supported by biological plausibility, but empirical evidence to support validity in epidemiological studies still lacking.
Read More »Omega 3 Fatty Acid Supplementation in Type 2 Diabetes
Trial assesses cardiovascular benefit in patients with diabetes.
Read More »Glycemic Variability and Development of Retinopathy
Study assesses glycemic variability via continuous glucose monitoring and compares it against incidence of diabetic retinopathy to determine if correlation exists.
Read More »More Reasons To Use Statins For Diabetes Treatment
Development of diabetic retinopathy found to be significantly reduced.
Read More »Comparative Efficacy of Insulin Pumps vs Multiple Daily Injections for Pregnant Patients with Type 1 Diabetes
Trial examines differences in glycemic control and quality of life when using different insulin delivery methods.
Read More »